IPO registrations (S-1, F-1) · Registrants

Turn Therapeutics Inc.

SEC CIK
2023016 · filings on EDGAR ↗
Former names
Global Health Solutions, Inc (2024–2025)
Registration
Form S-1, first filed 2025-09-02, last 2025-10-09; 2 initial registrations, 2 amendments
Outcome
Final prospectus filed 2025-10-08; declared effective 2025-09-30
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
250 NORTH WESTLAKE BLVD., #210, Westlake Village, CA 91362
EIN
32-0456090
Ticker
TTRX (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Turn Therapeutics Inc. on the corporate pages

Offering terms

Final price
$11.65 per share (424B4 filed 2025-10-08, an initial public offering)
Shares sold
17,868,760
Gross proceeds
$208,171,054 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol TTRX

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 8

FiledFormWhat it isName as filedEDGAR
2025-09-02S-1S-1 (registration)Global Health Solutions, Inc0001104659-25-085850 ↗
2025-09-16S-1/AS-1/A (amendment)Global Health Solutions, Inc0001104659-25-090474 ↗
2025-09-24S-1/AS-1/A (amendment)Global Health Solutions, Inc0001104659-25-092994 ↗
2025-09-30EFFECTEFFECT (declared effective)Global Health Solutions, Inc9999999995-25-003218 ↗
2025-10-08424B4424B4 (final prospectus)Turn Therapeutics Inc.0001104659-25-097840 ↗
2025-10-09S-1S-1 (registration)Turn Therapeutics Inc.0001104659-25-098363 ↗
2026-04-02EFFECTEFFECT (declared effective)Turn Therapeutics Inc.9999999995-26-001062 ↗
2026-04-02EFFECTEFFECT (declared effective)Turn Therapeutics Inc.9999999995-26-001065 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2025-09-24S-1/Aregistration statement$11.6517,868,760$208,171,054Nasdaq TTRX0primary document; price sentence, shares headline, proceeds computeddocument ↗
2025-10-08424B4final prospectus$11.6517,868,760$208,171,054Nasdaq TTRX0primary document; price sentence, shares headline, proceeds computeddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BEB Holdings, LLCTenPercentOwner42025–2026
Burnam Bradley EvanDirector,Officer,TenPercentOwnerChief Executive Officer42025–2026
Chaudhary ZuraizOfficerSee Remarks72025–2026
Gengos AndrewDirector32025–2026
Ghodadra Neilesh ShaileshDirector,OfficerChief Medical Officer22025
GOLDEN ARTHUR FDirector72025–2026person page Fuzzy
Kester Kent EdwardDirector32025–2026
Chesed AbrahamOther12025
Dewhurst Martin WilliamDirector32026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2026-08-26Turn Therapeutics Inc.BiotechnologyIndefinite$1,650,00081

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorGLOBAL HEALTH SOLUTIONS, INC. DBA TURN THERAPEUTICSCAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerTurn Therapeutics Inc.CAForm D private offeringsCIK (EXACT)
Lobbying clientTURN THERAPEUTICSCAFederal lobbying (LDA)name and state
Lobbying clientTURN THERAPEUTICSCAFederal lobbying (LDA)name and state
NonprofitTHE BURNAM FOUNDATIONCANonprofits (IRS Form 990)same street address and ZIP code, 250 N WESTLAKE BLVD STE 210 91362 (FUZZY: a shared address, not proof of a shared organization)
SEC filerTurn Therapeutics Inc.SEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorGLOBAL HEALTH SOLUTIONS, INC. DBA TURN THERAPEUTICSEIN (EXACT)
Person pageArthur F GoldenPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health